MIRCERA 150 micrograms/0.3 ml, solution for injection in a pre-filled syringe syringe, 0.3 ml
Active ingredients: Methoxy polyethylene glycol-epoetin beta
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.3 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIRCERA 150 microgrammes/0,3 ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,3 ml avec aiguille(s)
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69250216CIP73815180CIP133400938151800Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHOXY POLYÉTHYLÈNE GLYCOL-ÉPOÉTINE BÊTAsolution | 150 microgrammes · une seringue préremplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.